44 results
8-K
EX-99.1
CGTX
Cognition Therapeutics Inc
26 Mar 24
Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update
7:12am
engagement in the journal, Translational Neurodegeneration
Presented extensive research at scientific and medical congresses from our proteomics
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
engagement and assess changes in neurodegeneration and disease progression. We are conducting this clinical trial in collaboration with the Alzheimer’s … , and ADAS-Cog, we intend to use a variety of biomarkers to measure target and/or pathway engagement and assess changes in neurodegeneration and disease
424B5
CGTX
Cognition Therapeutics Inc
11 Mar 24
Prospectus supplement for primary offering
4:06pm
of Boxes, or SB, and ADAS-Cog, we intend to use a variety of biomarkers to measure target and/or pathway engagement and assess changes in neurodegeneration … of biomarkers to measure target and/or pathway engagement and assess changes in neurodegeneration and disease progression. We are conducting
424B4
ropi6u
8 Jan 24
Prospectus supplement with pricing info
4:11pm
8-K
EX-99.1
pioe7kxdg8jyzx ofzxl
4 Jan 24
Other Events
4:21pm
8-K
EX-99.1
bw3zafqsmm47ekqt
12 Sep 23
Other Events
7:00am
8-K
EX-99.1
cowjput11tsm0c fquz
24 Aug 23
Regulation FD Disclosure
7:00am
8-K
EX-99.1
znndebuh15g 5xj
8 Aug 23
Cognition Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
wdcm87e3h6n3b gipr
28 Jun 23
Cognition Therapeutics Announces Positive Topline Results for CT1812 Phase 2 SEQUEL Study for Mild-to-Moderate Alzheimer’s Disease
7:27am
8-K
EX-99.2
y3xd7
28 Jun 23
Cognition Therapeutics Announces Positive Topline Results for CT1812 Phase 2 SEQUEL Study for Mild-to-Moderate Alzheimer’s Disease
7:27am
8-K
EX-99.1
260gc7
19 Apr 23
Developing disease-modifying medicines for degenerative disorders Analyst Breakfast April 2023
7:30am
S-3
r3kay76x9lbexa4
23 Dec 22
Shelf registration
4:16pm
8-K
EX-99.1
lhi5o6ayxoqcs9y2bqd3
16 Nov 22
Developing disease - modifying medicines for degenerative disorders November 2022
5:18pm
424B4
jmbc1p 0e
14 Nov 22
Prospectus supplement with pricing info
6:02am